Table of Contents

company-logo

GENinCode Plc engages in the development and commercialization of clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies. The company's molecular tests combine clinical algorithms and artificial intelligence to provide advanced patient risk assessment to predict disease onset. Its tests include Cardio inCode, a patented genetic test to help user to adopt cardiovascular prevention steps; Lipid inCode, a genetic diagnostic test, which analyzes the seven genes associated with familial hypercholesterolemia; SUDD inCode, a genetic test to diagnose the cause of sudden cardiac death and familial heart disease; Thrombo inCode, a genetic test that analyzes 12 genetic variants related to hereditary thrombophilia and the risk of thrombosis; and Thrombo inCode Reproductive Health, a genetic test that offers information related to risk of thrombophilia and associated risks for future pregnancies. GENinCode Plc was incorporated in 2018 and is based in Oxford, the United Kingdom.

GENinCode Dividend Announcement

• GENinCode does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on GENinCode dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

GENinCode Dividend History

GENinCode Dividend Yield

GENinCode current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing GENinCode stock? Use our calculator to estimate your expected dividend yield:

GENinCode Financial Ratios

P/E ratio-1.11
PEG ratio-1.11
P/B ratio2.35
ROE-289.74%
Payout ratio0.00%
Current ratio2.60
Quick ratio2.55
Cash Ratio1.97

GENinCode Dividend FAQ

Does GENinCode stock pay dividends?
GENinCode does not currently pay dividends to its shareholders.
Has GENinCode ever paid a dividend?
No, GENinCode has no a history of paying dividends to its shareholders. GENinCode is not known for its dividend payments.
Why doesn't GENinCode pay dividends?
There are several potential reasons why GENinCode would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will GENinCode ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While GENinCode has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is GENinCode a dividend aristocrat?
GENinCode is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is GENinCode a dividend king?
GENinCode is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is GENinCode a dividend stock?
No, GENinCode is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy GENinCode stocks?
To buy GENinCode you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy GENinCode stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.